Literature DB >> 25409592

Hippocampal volume in healthy controls given 3-day stress doses of hydrocortisone.

E Sherwood Brown1, Haekyung Jeon-Slaughter1, Hanzhang Lu2, Rhoda Jamadar1, Sruthy Issac1, Mujeeb Shad1, Daren Denniston1, Carol Tamminga1, Alyson Nakamura1, Binu P Thomas2.   

Abstract

In animal models, corticosterone elevations are associated with hippocampal changes that can be prevented with phenytoin. In humans, Cushing's syndrome and long-term prescription corticosteroid use are associated with a reduction in the hippocampal volume. However, little is known about the effects of short-term corticosteroid administration on the hippocampus. The current report examines changes in the hippocampal volume during a brief hydrocortisone exposure and whether volumetric changes can be blocked by phenytoin. A randomized, double-blind, placebo-controlled, within-subject crossover study was conducted in healthy adults (n=17). Participants received hydrocortisone (160 mg/day)/placebo, phenytoin/placebo, both medications together, or placebo/placebo, with 21-day washouts between the conditions. Structural MRI scans and cortisol levels were obtained following each medication condition. No significant difference in the total brain volume was observed with hydrocortisone. However, hydrocortisone was associated with a significant 1.69% reduction in the total hippocampal volume compared with placebo. Phenytoin blocked the volume reduction associated with hydrocortisone. Reduction in hippocampal volume correlated with the change in cortisol levels (r=-0.58, P=0.03). To our knowledge, this is the first report of structural hippocampal changes with brief corticosteroid exposure. The correlation between the change in hippocampal volume and cortisol level suggests that the volume changes are related to cortisol elevation. Although the findings from this pilot study need replication, they suggest that the reductions in hippocampal volume occur even during brief exposure to corticosteroids, and that hippocampal changes can, as in animal models, be blocked by phenytoin. The results may have implications both for understanding the response of the hippocampus to stress as well as for patients receiving prescription corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25409592      PMCID: PMC4367466          DOI: 10.1038/npp.2014.307

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  40 in total

Review 1.  Controversies surrounding glucocorticoid-mediated cell death in the hippocampus.

Authors:  L P Reagan; B S McEwen
Journal:  J Chem Neuroanat       Date:  1997-08       Impact factor: 3.052

2.  Chronic stress alters synaptic terminal structure in hippocampus.

Authors:  A M Magariños; J M Verdugo; B S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

3.  Hippocampal damage associated with prolonged and fatal stress in primates.

Authors:  H Uno; R Tarara; J G Else; M A Suleman; R M Sapolsky
Journal:  J Neurosci       Date:  1989-05       Impact factor: 6.167

4.  Mood and memory changes in asthmatic children receiving corticosteroids.

Authors:  B G Bender; J A Lerner; E Kollasch
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1988-11       Impact factor: 8.829

5.  Hippocampal damage associated with prolonged glucocorticoid exposure in primates.

Authors:  R M Sapolsky; H Uno; C S Rebert; C E Finch
Journal:  J Neurosci       Date:  1990-09       Impact factor: 6.167

6.  Early changes in peritumorous oedema and contralateral white matter after dexamethasone: a study using proton magnetic resonance spectroscopy.

Authors:  P Chumas; B Condon; D Oluoch-Olunya; S Griffiths; D Hadley; G Teasdale
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

7.  Effectiveness of prednisolone during phenytoin therapy.

Authors:  L B Petereit; A W Meikle
Journal:  Clin Pharmacol Ther       Date:  1977-12       Impact factor: 6.875

8.  Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome.

Authors:  M N Starkman; S S Gebarski; S Berent; D E Schteingart
Journal:  Biol Psychiatry       Date:  1992-11-01       Impact factor: 13.382

Review 9.  Neurotoxicity of glucocorticoids in the primate brain.

Authors:  H Uno; S Eisele; A Sakai; S Shelton; E Baker; O DeJesus; J Holden
Journal:  Horm Behav       Date:  1994-12       Impact factor: 3.587

10.  Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy.

Authors:  E Sherwood Brown; Dixie J Woolston; Alan Frol; Leonardo Bobadilla; David A Khan; Margaret Hanczyc; A John Rush; James Fleckenstein; Evelyn Babcock; C Munro Cullum
Journal:  Biol Psychiatry       Date:  2004-03-01       Impact factor: 13.382

View more
  14 in total

Review 1.  Corticosteroids and Cognition: A Meta-Analysis.

Authors:  Catherine E Prado; Simon F Crowe
Journal:  Neuropsychol Rev       Date:  2019-05-26       Impact factor: 7.444

Review 2.  Behavioral and structural adaptations to stress.

Authors:  Heather A Cameron; Timothy J Schoenfeld
Journal:  Front Neuroendocrinol       Date:  2018-02-05       Impact factor: 8.606

3.  Stress and Loss of Adult Neurogenesis Differentially Reduce Hippocampal Volume.

Authors:  Timothy J Schoenfeld; Hayley C McCausland; H Douglas Morris; Varun Padmanaban; Heather A Cameron
Journal:  Biol Psychiatry       Date:  2017-05-22       Impact factor: 13.382

4.  Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment.

Authors:  M M Jukić; N Opel; J Ström; T Carrillo-Roa; S Miksys; M Novalen; A Renblom; S C Sim; E M Peñas-Lledó; P Courtet; A Llerena; B T Baune; D J de Quervain; A Papassotiropoulos; R F Tyndale; E B Binder; U Dannlowski; M Ingelman-Sundberg
Journal:  Mol Psychiatry       Date:  2016-11-29       Impact factor: 15.992

5.  Reduced DNA methylation of FKBP5 in Cushing's syndrome.

Authors:  Eugenia Resmini; Alicia Santos; Anna Aulinas; Susan M Webb; Yolanda Vives-Gilabert; Olivia Cox; Gary Wand; Richard S Lee
Journal:  Endocrine       Date:  2016-09-23       Impact factor: 3.633

6.  Hippocampal volume in patients with asthma: Results from the Dallas Heart Study.

Authors:  Scott M Carlson; Julie Kim; David A Khan; Kevin King; Richard T Lucarelli; Roderick McColl; Ronald Peshock; E Sherwood Brown
Journal:  J Asthma       Date:  2016-05-17       Impact factor: 2.515

Review 7.  Neurobiological mechanisms underlying sex-related differences in stress-related disorders: Effects of neuroactive steroids on the hippocampus.

Authors:  Katharina M Hillerer; David A Slattery; Belinda Pletzer
Journal:  Front Neuroendocrinol       Date:  2019-09-30       Impact factor: 8.606

8.  A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus.

Authors:  E Sherwood Brown; Nasreen Sayed; Changho Choi; Nicholas Tustison; Jared Roberts; Michael A Yassa; Erin Van Enkevort; Alyson Nakamura; Elena I Ivleva; Prabha Sunderajan; David A Khan; Miguel Vazquez; Bruce McEwen; Alexandra Kulikova; Alan B Frol; Traci Holmes
Journal:  Eur Neuropsychopharmacol       Date:  2019-01-03       Impact factor: 5.415

9.  Moderating Effects of Cortisol on Neural-Cognitive Association in Cognitively Normal Elderly Subjects.

Authors:  Way K W Lau; Mei Kei Leung; Andrew C K Law; Tatia M C Lee
Journal:  Front Aging Neurosci       Date:  2017-05-24       Impact factor: 5.750

Review 10.  Short-term mechanisms influencing volumetric brain dynamics.

Authors:  Nikki Dieleman; Huiberdina L Koek; Jeroen Hendrikse
Journal:  Neuroimage Clin       Date:  2017-09-06       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.